Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder.

Duval JV, Savas L, Banner BF.

Arch Pathol Lab Med. 2000 Aug;124(8):1196-200.

PMID:
10923083
[PubMed - indexed for MEDLINE]
2.

Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.

Cabibi D, Licata A, Barresi E, Craxì A, Aragona F.

Pathol Res Pract. 2003;199(2):65-70.

PMID:
12747467
[PubMed - indexed for MEDLINE]
3.

Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P.

Am J Surg Pathol. 2000 Jun;24(6):870-6.

PMID:
10843291
[PubMed - indexed for MEDLINE]
4.

The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.

Tot T, Samii S.

APMIS. 2003 Dec;111(12):1075-82.

PMID:
14678015
[PubMed - indexed for MEDLINE]
5.
6.

Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.

Sung JY, Kim GY, Lim SJ, Park YK, Kim YW.

Pathol Res Pract. 2010 Jan 15;206(1):24-9. doi: 10.1016/j.prp.2009.07.018. Epub 2009 Oct 12.

PMID:
19819644
[PubMed - indexed for MEDLINE]
7.

Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.

Cai YC, Banner B, Glickman J, Odze RD.

Hum Pathol. 2001 Oct;32(10):1087-93.

PMID:
11679943
[PubMed - indexed for MEDLINE]
8.

Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.

Hoang MP, Murakata LA, Katabi N, Henson DE, Albores-Saavedra J.

Mod Pathol. 2002 Dec;15(12):1251-8.

PMID:
12481004
[PubMed - indexed for MEDLINE]
Free Article
9.

Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.

Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.

Hum Pathol. 2010 Nov;41(11):1558-65. doi: 10.1016/j.humpath.2009.12.016.

PMID:
20621328
[PubMed - indexed for MEDLINE]
10.
11.

Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.

Tot T.

Med Sci Monit. 2004 May;10(5):BR139-43. Epub 2004 Apr 28.

PMID:
15114262
[PubMed - indexed for MEDLINE]
12.

Spread of gallbladder carcinoma: CT evaluation with pathologic correlation.

Ohtani T, Shirai Y, Tsukada K, Muto T, Hatakeyama K.

Abdom Imaging. 1996 May-Jun;21(3):195-201.

PMID:
8661547
[PubMed - indexed for MEDLINE]
13.

Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.

Cancer. 2001 Oct 25;93(5):330-6.

PMID:
11668468
[PubMed - indexed for MEDLINE]
14.

Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.

Jiang J, Ulbright TM, Younger C, Sanchez K, Bostwick DG, Koch MO, Eble JN, Cheng L.

Arch Pathol Lab Med. 2001 Jul;125(7):921-3.

PMID:
11419977
[PubMed - indexed for MEDLINE]
15.

Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Chuang SC, Lee KT, Tsai KB, Sheen PC, Nagai E, Mizumoto K, Tanaka M.

World J Surg. 2004 Oct;28(10):995-1000. Epub 2004 Sep 29.

PMID:
15573254
[PubMed - indexed for MEDLINE]
16.

Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.

Tatsumi N, Mukaisho K, Mitsufuji S, Tatsumi Y, Sugihara H, Okanoue T, Hattori T.

Dig Dis Sci. 2005 Sep;50(9):1741-6.

PMID:
16133982
[PubMed - indexed for MEDLINE]
17.

Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.

Okami J, Dohno K, Sakon M, Iwao K, Yamada T, Yamamoto H, Fujiwara Y, Nagano H, Umeshita K, Matsuura N, Nakamori S, Monden M.

Clin Cancer Res. 2000 Jun;6(6):2326-32.

PMID:
10873083
[PubMed - indexed for MEDLINE]
Free Article
18.

Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.

Kamisawa T, Tu Y, Kuwata G, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Matsukawa M.

Hepatogastroenterology. 2006 Nov-Dec;53(72):816-8.

PMID:
17153430
[PubMed - indexed for MEDLINE]
19.

Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.

Henson DE, Schwartz AM, Nsouli H, Albores-Saavedra J.

Arch Pathol Lab Med. 2009 Jan;133(1):67-71. doi: 10.1043/1543-2165-133.1.67.

PMID:
19123739
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk